Primary breast double-hit lymphoma management and outcomes: a real-world multicentre experience
Abstract Background Primary breast double-hit lymphoma (PB-DHL) is a rare, highly aggressive malignancy that poses challenges regarding accurate diagnosis and selecting optimal treatment regimens. Methods We retrospectively reviewed 48 cases of patients diagnosed with PB-DHL in six academic centres...
Main Authors: | Tingting Zhang, Yuanfeng Zhang, Hairong Fei, Xue Shi, Liang Wang, Peijun Wang, Jie Yu, Yuyan Shen, Sizhou Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02198-y |
Similar Items
-
Drug therapy for double-hit lymphoma
by: Vania Phuoc, et al.
Published: (2019-12-01) -
Double-Hit and Triple-Hit Lymphomas: New Perspectives for Their Classification
by: Cristiano Claudino Oliveira, et al.
Published: (2017-08-01) -
Clinical features and therapy of double-hit and double-expressor lymphomas
by: E A Baryakh, et al.
Published: (2016-12-01) -
Successful treatment of a patient with two hematologic tumors: double-hit lymphoma and acute myelomonoblastic leukemia
by: A E Lukina, et al.
Published: (2014-07-01) -
Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent <it>MYC</it> and <it>BCL2</it> rearrangements
by: Hooper Sean D, et al.
Published: (2012-11-01)